Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer

医学 免疫疗法 内科学 肺癌 肿瘤科 放射治疗 癌症 胃肠病学 免疫学
作者
Yeona Cho,Sang Joon Park,Hwa Kyung Byun,Chang Geol Lee,Jaeho Cho,Min Hee Hong,Hye Ryun Kim,Byoung Chul Cho,Sinae Kim,Juyoung Park,Hong In Yoon
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:105 (5): 1065-1073 被引量:124
标识
DOI:10.1016/j.ijrobp.2019.08.047
摘要

Purpose The interest in combining radiation therapy (RT) with immunotherapy is increasing. We investigated the significance of lymphopenia in patients receiving immunotherapy for non-small cell lung cancer (NSCLC), and the factors associated with treatment-related lymphopenia, with particular emphasis on RT. Methods and Methods In this retrospective single institution study, 268 patients with advanced NSCLC received immunotherapy, of whom 146 received RT. Lymphopenia was defined as an absolute lymphocyte count <1000 cells/mm.3 Patients were divided into 2 groups depending on the presence of peri-immunotherapy lymphopenia at the start of immunotherapy or during immunotherapy. Results At median 6.4 months of follow-up, patients with peri-immunotherapy lymphopenia (n = 146; 54.5%) showed significantly poorer progression-free survival (PFS) (median PFS: 2.2 vs 5.9 months, P < .001) and overall survival (OS) (median OS: 5.7 vs 12.1 months, P < .001). On multivariate analysis, peri-immunotherapy lymphopenia remained a significant prognostic factor for both PFS and OS. RT significantly increased peri-immunotherapy lymphopenia with an odds ratio (OR) of 1.91 (P = .025). Factors associated with the development of RT-associated lymphopenia included multiple courses (OR, 3.78; P < .001), multiple irradiated sites (OR, 4.77; P = .018), and higher dose (≥50 Gy) (OR, 3.75; P = .004). Conversely, stereotactic body RT/radiosurgery reduced the risk (OR 0.21; P = .002). Conclusions Lymphopenia was indicative of poor prognosis in NSCLC patients receiving immunotherapy and was significantly associated with more intensive RT. Choosing appropriate RT regimens and techniques may be essential in reducing lymphopenia. Promising results are expected in the era of precision RT. The interest in combining radiation therapy (RT) with immunotherapy is increasing. We investigated the significance of lymphopenia in patients receiving immunotherapy for non-small cell lung cancer (NSCLC), and the factors associated with treatment-related lymphopenia, with particular emphasis on RT. In this retrospective single institution study, 268 patients with advanced NSCLC received immunotherapy, of whom 146 received RT. Lymphopenia was defined as an absolute lymphocyte count <1000 cells/mm.3 Patients were divided into 2 groups depending on the presence of peri-immunotherapy lymphopenia at the start of immunotherapy or during immunotherapy. At median 6.4 months of follow-up, patients with peri-immunotherapy lymphopenia (n = 146; 54.5%) showed significantly poorer progression-free survival (PFS) (median PFS: 2.2 vs 5.9 months, P < .001) and overall survival (OS) (median OS: 5.7 vs 12.1 months, P < .001). On multivariate analysis, peri-immunotherapy lymphopenia remained a significant prognostic factor for both PFS and OS. RT significantly increased peri-immunotherapy lymphopenia with an odds ratio (OR) of 1.91 (P = .025). Factors associated with the development of RT-associated lymphopenia included multiple courses (OR, 3.78; P < .001), multiple irradiated sites (OR, 4.77; P = .018), and higher dose (≥50 Gy) (OR, 3.75; P = .004). Conversely, stereotactic body RT/radiosurgery reduced the risk (OR 0.21; P = .002). Lymphopenia was indicative of poor prognosis in NSCLC patients receiving immunotherapy and was significantly associated with more intensive RT. Choosing appropriate RT regimens and techniques may be essential in reducing lymphopenia. Promising results are expected in the era of precision RT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
好晨阳发布了新的文献求助30
1秒前
2秒前
haishixigua完成签到,获得积分10
3秒前
3秒前
LXP发布了新的文献求助10
3秒前
3秒前
4秒前
酷波er应助hei采纳,获得10
4秒前
火星完成签到 ,获得积分10
4秒前
5秒前
傻傻的小刺猬完成签到,获得积分10
5秒前
科研通AI2S应助陌路孤星采纳,获得10
6秒前
6秒前
7秒前
8秒前
8秒前
12123ray发布了新的文献求助10
8秒前
9秒前
moomoo完成签到 ,获得积分10
10秒前
zw发布了新的文献求助10
10秒前
Orange应助俏皮念寒采纳,获得10
10秒前
Donby发布了新的文献求助30
10秒前
10秒前
从容的从寒完成签到,获得积分10
12秒前
迅速采波发布了新的文献求助10
12秒前
黑苹果发布了新的文献求助10
13秒前
jiajia发布了新的文献求助10
13秒前
巡音幻夜发布了新的文献求助10
13秒前
嘉子发布了新的文献求助10
13秒前
14秒前
慕青应助彩色蘑菇采纳,获得10
14秒前
SHD发布了新的文献求助10
15秒前
KKKKK完成签到,获得积分10
15秒前
ylq发布了新的文献求助10
15秒前
15秒前
iNk应助LinX采纳,获得10
16秒前
qingzhiwu完成签到,获得积分10
17秒前
17秒前
今夜不设防发布了新的文献求助150
18秒前
18秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974882
求助须知:如何正确求助?哪些是违规求助? 3519431
关于积分的说明 11198315
捐赠科研通 3255698
什么是DOI,文献DOI怎么找? 1797904
邀请新用户注册赠送积分活动 877237
科研通“疑难数据库(出版商)”最低求助积分说明 806219